Showing 121-130 of 3868 results for "".
Join Us for NewDerm LIVE: Welcome from the Chairs
https://practicaldermatology.com/topics/practice-management/join-us-for-newderm-live-welcome-from-the-chairs/18920/Join us September 18-20, 2015 at the W Hollywood, CA for NewDerm Live, the meeting that's focused on you—so you can focus on your future. Program chairs Sabrina Fabi, MD, Peter Lio, MD, and Kavita Mariwalla, MD, talk about the goals of the meeting and explain why they decided to be part of this exciNail Disease and JAK Inhibitor Safety
https://practicaldermatology.com/programs/practical-dermatology/nail-disease-and-jak-inhibitor-safety/35897/Brad Glick, DO, talks about the basics of nail anatomy, physiology, disease presentation, and treatments, as well as the safety of JAK inhibitors, at Music City SCALE 2025.Get Ready for JAK Inhibitors
https://practicaldermatology.com/topics/psoriasis/get-ready-for-jak-inhibitors/19928/JAK inhibitors are going to change the way we think about refractory disease, says Brett King, MD. He addresses the significant increase in study of these agents and the many potential uses for refractory diseases like alopecia, atopic dermatitis, vitiligo, psoriasis, and more.Dr. Joel Schlessinger discusses Botox treatments
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/dr-joel-schlessinger-discusses-botox-treatments/19321/Joel Schlessinger, MD takes you through a BOTOX treatment step-by-step, explaining each piece of the process. The video begins with a quick description of BOTOX, Dysport and Xeomin before moving on to show the process of taking pre-treatment photos and performing a consultation. Dr. Schlessinger thePatient-Centered Wound Healing
https://practicaldermatology.com/topics/feature/patient-centered-wound-healing/26645/Patient-Centered Wound HealingPhase 2 and 3 Trials of JAK Inhibitors For Atopic Dermatitis: A Review
https://practicaldermatology.com/topics/atopic-dermatitis/phase-2-and-3-trials-of-jak-inhibitors-for-atopic-dermatitis-a-review/23265/A number of drugs in development show promise for one of the most challening skin diseases.JAK Inhibitors in Hidradenitis Suppurativa: A Systematic Review
https://practicaldermatology.com/topics/feature/jak-inhibitors-in-hidradenitis-suppurativa-a-systematic-review/29887/Hidradenitis suppurativa (HS) is a chronic, disfiguring, debilitating, inflammatory disorder that is characterized by inflammatory nodules, abscesses, fistulae/ sinus tracts, and scarring to the axilla, inframammary folds, and groin.Home-Use Laser and Light Devices: Just What the Doctor Ordered
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/home-use-laser-and-light-devices-just-what-the-doctor-ordered/23335/Laser and light-based devices are more at home than ever as lightweight LEDs, wearable technology, and “smart” apps support adherence and enhance efficacy.Technology Solutions: Q&A With Nextech's Dr. Jason Handza
https://practicaldermatology.com/topics/practice-management/technology-solutions-q-nextechs-dr-jason-handza/28649/Nextech this year introduced Nextech RCM Professional Billing Services, an addition to their practice management software suite. This solution simplifies insurance billing complexities, helping practices reduce administrative burdens and enhance financial performance through optimized cash flow.Vitiligo: Oral and Topical JAKs Show Promise
https://practicaldermatology.com/topics/pigmentary-disorders/vitiligo-oral-and-topical-jaks-show-promise/23316/Early studies offer some hope for emerging therapies for repigmentation.